BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29400094)

  • 1. GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapy.
    Ling T; Crispino JD; Zingariello M; Martelli F; Migliaccio AR
    Expert Rev Hematol; 2018 Mar; 11(3):169-184. PubMed ID: 29400094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular convergence in ex vivo models of Diamond-Blackfan anemia.
    O'Brien KA; Farrar JE; Vlachos A; Anderson SM; Tsujiura CA; Lichtenberg J; Blanc L; Atsidaftos E; Elkahloun A; An X; Ellis SR; Lipton JM; Bodine DM
    Blood; 2017 Jun; 129(23):3111-3120. PubMed ID: 28377399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis.
    Gilles L; Arslan AD; Marinaccio C; Wen QJ; Arya P; McNulty M; Yang Q; Zhao JC; Konstantinoff K; Lasho T; Pardanani A; Stein B; Plo I; Sundaravel S; Wickrema A; Migliaccio A; Gurbuxani S; Vainchenker W; Platanias LC; Tefferi A; Crispino JD
    J Clin Invest; 2017 Apr; 127(4):1316-1320. PubMed ID: 28240607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA1 Is a Sensitive and Specific Nuclear Marker for Erythroid and Megakaryocytic Lineages.
    Lee WY; Weinberg OK; Pinkus GS
    Am J Clin Pathol; 2017 Apr; 147(4):420-426. PubMed ID: 28340113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1.
    Rio S; Gastou M; Karboul N; Derman R; Suriyun T; Manceau H; Leblanc T; El Benna J; Schmitt C; Azouzi S; Larghéro J; Karim Z; Macias-Garcia A; Chen JJ; Hermine O; Courtois G; Puy H; Gouya L; Mohandas N; Da Costa L
    Blood; 2019 Mar; 133(12):1358-1370. PubMed ID: 30700418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
    Xavier AC; Edwards H; Dombkowski AA; Balci TB; Berman JN; Dellaire G; Xie C; Buck SA; Matherly LH; Ge Y; Taub JW
    PLoS One; 2011; 6(11):e27486. PubMed ID: 22110660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA factor mutations in hematologic disease.
    Crispino JD; Horwitz MS
    Blood; 2017 Apr; 129(15):2103-2110. PubMed ID: 28179280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB1 Chromatin Loops Regulate Megakaryocyte/Erythroid Progenitor Expansion by Facilitating HSP70 and GATA1 Induction.
    Wilkes MC; Chae HD; Scanlon V; Cepika AM; Wentworth EP; Saxena M; Eskin A; Chen Z; Glader B; Grazia Roncarolo M; Nelson SF; Sakamoto KM
    Stem Cells; 2023 Jun; 41(6):560-569. PubMed ID: 36987811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cell model of early hematopoiesis in Down syndrome reveals quantitative effects of short-form GATA1 protein on lineage specification.
    Matsuo S; Nishinaka-Arai Y; Kazuki Y; Oshimura M; Nakahata T; Niwa A; Saito MK
    PLoS One; 2021; 16(3):e0247595. PubMed ID: 33780474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
    Rainis L; Bercovich D; Strehl S; Teigler-Schlegel A; Stark B; Trka J; Amariglio N; Biondi A; Muler I; Rechavi G; Kempski H; Haas OA; Izraeli S
    Blood; 2003 Aug; 102(3):981-6. PubMed ID: 12649131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1.
    Stachura DL; Chou ST; Weiss MJ
    Blood; 2006 Jan; 107(1):87-97. PubMed ID: 16144799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targets to cure primary myelofibrosis from studies on Gata1
    Zingariello M; Martelli F; Verachi P; Bardelli C; Gobbo F; Mazzarini M; Migliaccio AR
    IUBMB Life; 2020 Jan; 72(1):131-141. PubMed ID: 31749302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
    Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
    Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of GATA1 dysfunction to multi-step leukemogenesis.
    Shimizu R; Yamamoto M
    Cancer Sci; 2012 Dec; 103(12):2039-44. PubMed ID: 22937757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis.
    Gutiérrez L; Tsukamoto S; Suzuki M; Yamamoto-Mukai H; Yamamoto M; Philipsen S; Ohneda K
    Blood; 2008 Apr; 111(8):4375-85. PubMed ID: 18258797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression.
    Chlon TM; McNulty M; Goldenson B; Rosinski A; Crispino JD
    Haematologica; 2015 May; 100(5):575-84. PubMed ID: 25682601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model.
    Arkoun B; Robert E; Boudia F; Mazzi S; Dufour V; Siret A; Mammasse Y; Aid Z; Vieira M; Imanci A; Aglave M; Cambot M; Petermann R; Souquere S; Rameau P; Catelain C; Diot R; Tachdjian G; Hermine O; Droin N; Debili N; Plo I; Malinge S; Soler E; Raslova H; Mercher T; Vainchenker W
    J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35587378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.
    Wang C; Hu M; Yu K; Liu W; Hu A; Kuang Y; Huang L; Gajendran B; Zacksenhaus E; Xiao X; Ben-David Y
    Mol Med Rep; 2024 Jun; 29(6):. PubMed ID: 38695236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromatin occupancy and epigenetic analysis reveal new insights into the function of the GATA1 N terminus in erythropoiesis.
    Ling T; Birger Y; Stankiewicz MJ; Ben-Haim N; Kalisky T; Rein A; Kugler E; Chen W; Fu C; Zhang K; Patel H; Sikora JW; Goo YA; Kelleher N; Zou L; Izraeli S; Crispino JD
    Blood; 2019 Nov; 134(19):1619-1631. PubMed ID: 31409672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
    Greene ME; Mundschau G; Wechsler J; McDevitt M; Gamis A; Karp J; Gurbuxani S; Arceci R; Crispino JD
    Blood Cells Mol Dis; 2003; 31(3):351-6. PubMed ID: 14636651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.